HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cagla Kayabasi Selected Research

Cagla Kayabasi Research Topics

Disease

5BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 10/2014
3Neoplasms (Cancer)
01/2022 - 10/2014
3Leukemia
01/2022 - 12/2017
2Carcinoma (Carcinomatosis)
02/2016 - 09/2015
1Hematologic Diseases (Blood Diseases)
01/2022
1Breast Neoplasms (Breast Cancer)
03/2021
1Melanoma (Melanoma, Malignant)
01/2021
1Hepatitis B
05/2018
1Liver Neoplasms (Liver Cancer)
05/2018
1Brain Neoplasms (Brain Tumor)
09/2016
1Glioblastoma (Glioblastoma Multiforme)
09/2016

Drug/Important Bio-Agent (IBA)

5ponatinibIBA
01/2022 - 10/2014
3Long Noncoding RNAIBA
01/2022 - 09/2016
2bcr-abl Fusion ProteinsIBA
12/2017 - 10/2014
21-phenyl-3,3-dimethyltriazene (PDT)IBA
02/2016 - 09/2015
1Dasatinib (BMS 354825)FDA Link
01/2022
1Tyrosine Kinase InhibitorsIBA
01/2022
1Methanol (Carbinol)IBA
01/2022
1VS-5584IBA
11/2021
1caffeic acid phenethyl esterIBA
03/2021
13- ((4- (6- bromo- 2- (4- (4- methylpiperazin- 1- yl)phenyl)- 3H- imidazo(4,5- b)pyridin- 7- yl)piperazin- 1- yl)methyl)- 5- methylisoxazoleIBA
01/2021
1Aurora KinasesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
05/2018
1Small Interfering RNA (siRNA)IBA
05/2018
1MicroRNAs (MicroRNA)IBA
12/2017
1Imatinib Mesylate (Gleevec)FDA Link
12/2017
1Photosensitizing Agents (Photosensitizers)IBA
09/2015
1PolyphenolsIBA
10/2014
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2014
1TeaIBA
10/2014

Therapy/Procedure

1Aftercare (After-Treatment)
01/2022
1Therapeutics
12/2017
1Photochemotherapy (Photodynamic Therapy)
09/2015
1Radiotherapy
09/2015
1Drug Therapy (Chemotherapy)
09/2015